KKR Acquires India's Healthium Medtech from Apax Partners Deal Analysis

07 May, 2024

KKR Acquires India's Healthium Medtech from Apax Partners Deal Analysis

With the support of Apax Funds, Healthium bolstered its management team, appointing Anish Bafna as CEO and Vishal Maheshwari as CFO, adding deep industry experience and positioning the company for growth. Global investment giant KKR announced on May 6 the signing of definitive agreements to acquire Healthium Medtech Ltd, a leading Indian medical devices company, from an affiliate of funds advised by Apax Partners LLP, a prominent global private equity advisory firm.

Moneycontrol first reported on May 4 that KKR had emerged as the front-runner to acquire Healthium Medtech in a deal potentially valuing the firm at up to $850 million.

The acquisition will be executed through a special purpose vehicle owned by KKR-managed funds, facilitating a controlling interest in the Healthium group, including Healthium itself.

Founded in India in 1992, Healthium is a medical devices company specializing in the development, manufacture, and global distribution of a diverse range of surgical products. Its comprehensive portfolio of high-quality offerings caters to various surgical needs, encompassing wound closure, arthroscopy, and advanced wound closure products.